SRPT Annual Total Expenses
$1.51 B
+$41.95 M+2.85%
31 December 2023
Summary:
As of January 22, 2025, SRPT annual total expenses is $1.51 billion, with the most recent change of +$41.95 million (+2.85%) on December 31, 2023. During the last 3 years, it has risen by +$406.90 million (+36.85%). SRPT annual total expenses is now at all-time high.SRPT Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Quarterly Total Expenses
$444.98 M
+$81.34 M+22.37%
30 September 2024
Summary:
As of January 22, 2025, SRPT quarterly total expenses is $444.98 million, with the most recent change of +$81.34 million (+22.37%) on September 30, 2024. Over the past year, it has increased by +$72.82 million (+19.57%). SRPT quarterly total expenses is now at all-time high.SRPT Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.9% | +19.6% |
| 3 y3 years | +36.9% | +23.1% |
| 5 y5 years | +134.4% | +23.1% |
SRPT Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.2% | at high | +49.5% |
| 5 y | 5-year | at high | +67.3% | at high | +98.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Sarepta Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $444.98 M(+22.4%) |
| June 2024 | - | $363.63 M(-3.9%) |
| Mar 2024 | - | $378.56 M(+1.7%) |
| Dec 2023 | $1.51 B(+2.9%) | $372.16 M(+5.5%) |
| Sept 2023 | - | $352.66 M(-10.7%) |
| June 2023 | - | $394.76 M(+0.8%) |
| Mar 2023 | - | $391.59 M(+7.2%) |
| Dec 2022 | $1.47 B(+27.6%) | $365.26 M(+1.0%) |
| Sept 2022 | - | $361.62 M(-18.7%) |
| June 2022 | - | $444.62 M(+49.3%) |
| Mar 2022 | - | $297.71 M(-3.1%) |
| Dec 2021 | $1.15 B(+4.3%) | $307.27 M(+37.3%) |
| Sept 2021 | - | $223.86 M(-32.5%) |
| June 2021 | - | $331.66 M(+14.8%) |
| Mar 2021 | - | $288.80 M(-8.6%) |
| Dec 2020 | $1.10 B(+22.3%) | $315.85 M(+12.4%) |
| Sept 2020 | - | $280.99 M(+1.9%) |
| June 2020 | - | $275.72 M(+19.0%) |
| Mar 2020 | - | $231.70 M(-27.7%) |
| Dec 2019 | $903.16 M(+40.1%) | $320.33 M(+43.9%) |
| Sept 2019 | - | $222.63 M(+13.1%) |
| June 2019 | - | $196.79 M(+20.4%) |
| Mar 2019 | - | $163.40 M(-26.2%) |
| Dec 2018 | $644.66 M(+116.5%) | $221.56 M(+49.1%) |
| Sept 2018 | - | $148.59 M(-17.1%) |
| June 2018 | - | $179.18 M(+87.9%) |
| Mar 2018 | - | $95.34 M(+14.9%) |
| Dec 2017 | $297.80 M(+10.5%) | $83.01 M(+25.3%) |
| Sept 2017 | - | $66.27 M(-28.8%) |
| June 2017 | - | $93.09 M(+67.5%) |
| Mar 2017 | - | $55.59 M(-39.5%) |
| Dec 2016 | $269.60 M(+21.8%) | $91.91 M(+62.6%) |
| Sept 2016 | - | $56.53 M(-8.8%) |
| June 2016 | - | $61.98 M(+3.8%) |
| Mar 2016 | - | $59.70 M(-9.1%) |
| Dec 2015 | $221.44 M(+54.3%) | $65.70 M(+26.9%) |
| Sept 2015 | - | $51.76 M(+22.9%) |
| June 2015 | - | $42.11 M(-31.9%) |
| Mar 2015 | - | $61.86 M(+38.2%) |
| Dec 2014 | $143.55 M(+37.4%) | $44.75 M(+28.8%) |
| Sept 2014 | - | $34.73 M(+5.7%) |
| June 2014 | - | $32.85 M(+5.3%) |
| Mar 2014 | - | $31.21 M(-12.0%) |
| Dec 2013 | $104.50 M(+55.9%) | $35.48 M(+21.9%) |
| Sept 2013 | - | $29.10 M(+45.2%) |
| June 2013 | - | $20.04 M(+0.7%) |
| Mar 2013 | - | $19.89 M(+12.3%) |
| Dec 2012 | $67.03 M(-19.2%) | $17.70 M(+22.3%) |
| Sept 2012 | - | $14.48 M(-13.6%) |
| June 2012 | - | $16.76 M(-7.3%) |
| Mar 2012 | - | $18.09 M(-19.9%) |
| Dec 2011 | $82.92 M(+64.7%) | $22.59 M(+20.2%) |
| Sept 2011 | - | $18.80 M(-13.4%) |
| June 2011 | - | $21.71 M(+9.5%) |
| Mar 2011 | - | $19.83 M(+14.9%) |
| Dec 2010 | $50.35 M | $17.26 M(+38.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $12.50 M(+7.2%) |
| June 2010 | - | $11.66 M(+30.5%) |
| Mar 2010 | - | $8.94 M(-1.7%) |
| Dec 2009 | $33.09 M(-14.7%) | $9.10 M(-1.9%) |
| Sept 2009 | - | $9.27 M(+15.8%) |
| June 2009 | - | $8.01 M(+19.3%) |
| Mar 2009 | - | $6.71 M(-19.8%) |
| Dec 2008 | $38.80 M(-12.0%) | $8.37 M(-24.6%) |
| Sept 2008 | - | $11.11 M(+12.6%) |
| June 2008 | - | $9.86 M(+4.3%) |
| Mar 2008 | - | $9.46 M(-12.9%) |
| Dec 2007 | $44.09 M(+33.2%) | $10.85 M(-5.0%) |
| Sept 2007 | - | $11.43 M(+2.1%) |
| June 2007 | - | $11.19 M(+5.4%) |
| Mar 2007 | - | $10.62 M(+20.8%) |
| Dec 2006 | $33.10 M(+48.4%) | $8.79 M(+20.6%) |
| Sept 2006 | - | $7.29 M(-2.0%) |
| June 2006 | - | $7.44 M(-22.4%) |
| Mar 2006 | - | $9.59 M(+51.6%) |
| Dec 2005 | $22.30 M(-12.5%) | $6.32 M(+21.6%) |
| Sept 2005 | - | $5.20 M(+0.2%) |
| June 2005 | - | $5.19 M(-7.2%) |
| Mar 2005 | - | $5.59 M(+7.0%) |
| Dec 2004 | $25.47 M(+28.4%) | $5.22 M(+1.8%) |
| Sept 2004 | - | $5.13 M(-29.4%) |
| June 2004 | - | $7.27 M(-7.4%) |
| Mar 2004 | - | $7.85 M(+7.7%) |
| Dec 2003 | $19.84 M(-24.2%) | $7.29 M(+43.2%) |
| Sept 2003 | - | $5.09 M(+37.1%) |
| June 2003 | - | $3.72 M(-0.6%) |
| Mar 2003 | - | $3.74 M(-13.5%) |
| Dec 2002 | $26.18 M(+62.5%) | $4.32 M(-22.9%) |
| Sept 2002 | - | $5.60 M(-31.0%) |
| June 2002 | - | $8.12 M(-0.2%) |
| Mar 2002 | - | $8.13 M(+61.8%) |
| Dec 2001 | $16.11 M(+39.6%) | $5.03 M(+37.6%) |
| Sept 2001 | - | $3.65 M(-5.7%) |
| June 2001 | - | $3.87 M(+8.9%) |
| Mar 2001 | - | $3.56 M(+2.2%) |
| Dec 2000 | $11.54 M(+37.4%) | $3.48 M(+28.2%) |
| Sept 2000 | - | $2.71 M(-8.8%) |
| June 2000 | - | $2.97 M(+25.4%) |
| Mar 2000 | - | $2.37 M(-1.1%) |
| Dec 1999 | $8.40 M(+6.3%) | $2.40 M(+9.1%) |
| Sept 1999 | - | $2.20 M(+10.0%) |
| June 1999 | - | $2.00 M(+17.6%) |
| Mar 1999 | - | $1.70 M(-34.6%) |
| Dec 1998 | $7.90 M(+97.5%) | $2.60 M(+36.8%) |
| Sept 1998 | - | $1.90 M(+5.6%) |
| June 1998 | - | $1.80 M(+12.5%) |
| Mar 1998 | - | $1.60 M(+60.0%) |
| Dec 1997 | $4.00 M(+73.9%) | $1.00 M(0.0%) |
| Sept 1997 | - | $1.00 M(-23.1%) |
| June 1997 | - | $1.30 M(+85.7%) |
| Mar 1997 | - | $700.00 K |
| Dec 1996 | $2.30 M | - |
FAQ
- What is Sarepta Therapeutics annual total expenses?
- What is the all time high annual total expenses for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual total expenses year-on-year change?
- What is Sarepta Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly total expenses year-on-year change?
What is Sarepta Therapeutics annual total expenses?
The current annual total expenses of SRPT is $1.51 B
What is the all time high annual total expenses for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total expenses is $1.51 B
What is Sarepta Therapeutics annual total expenses year-on-year change?
Over the past year, SRPT annual total expenses has changed by +$41.95 M (+2.85%)
What is Sarepta Therapeutics quarterly total expenses?
The current quarterly total expenses of SRPT is $444.98 M
What is the all time high quarterly total expenses for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total expenses is $444.98 M
What is Sarepta Therapeutics quarterly total expenses year-on-year change?
Over the past year, SRPT quarterly total expenses has changed by +$72.82 M (+19.57%)